TW200740729A - Methods for preparing glutamic acid derivatives - Google Patents

Methods for preparing glutamic acid derivatives

Info

Publication number
TW200740729A
TW200740729A TW095125251A TW95125251A TW200740729A TW 200740729 A TW200740729 A TW 200740729A TW 095125251 A TW095125251 A TW 095125251A TW 95125251 A TW95125251 A TW 95125251A TW 200740729 A TW200740729 A TW 200740729A
Authority
TW
Taiwan
Prior art keywords
glutamic acid
acid derivatives
methods
preparing glutamic
preparing
Prior art date
Application number
TW095125251A
Other languages
English (en)
Inventor
Ronald S Michalak
Joseph Zeldis
Mel Jennings
David M Blum
Timothy Doyle
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of TW200740729A publication Critical patent/TW200740729A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18—Fluorenes; Hydrogenated fluorenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
TW095125251A 2005-10-13 2006-07-11 Methods for preparing glutamic acid derivatives TW200740729A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72644105P 2005-10-13 2005-10-13

Publications (1)

Publication Number Publication Date
TW200740729A true TW200740729A (en) 2007-11-01

Family

ID=37119907

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095125251A TW200740729A (en) 2005-10-13 2006-07-11 Methods for preparing glutamic acid derivatives

Country Status (18)

Country Link
US (1) US7541485B2 (zh)
EP (1) EP1934171A1 (zh)
JP (1) JP2009511578A (zh)
KR (1) KR20080058436A (zh)
CN (1) CN101282927A (zh)
AR (1) AR057451A1 (zh)
AU (1) AU2006299918A1 (zh)
BR (1) BRPI0617348A2 (zh)
CA (1) CA2624866A1 (zh)
CR (1) CR9885A (zh)
EC (1) ECSP088360A (zh)
GT (1) GT200600305A (zh)
IL (1) IL190729A0 (zh)
NO (1) NO20081617L (zh)
PE (1) PE20070526A1 (zh)
RU (1) RU2008113222A (zh)
TW (1) TW200740729A (zh)
WO (1) WO2007044100A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200808715A (en) * 2006-06-02 2008-02-16 Wyeth Corp Methods for preparing glutamic acid derivatives and intermediates thereof
US20100216886A1 (en) * 2006-11-09 2010-08-26 Wyeth Polymorphs of n2-(1,1'-biphenyl-4-ylcarbonyl)-n1-[2-(4-fluorophenyl)-1,1-dimethylethyl]-l-alpha-glutamine
CN110409221B (zh) * 2011-09-30 2022-08-09 凯米拉公司 纸浆、纸或板制造方法中淀粉降解的防止
JP6463366B2 (ja) 2013-10-10 2019-01-30 イースタン バージニア メディカル スクール １２−リポキシゲナーゼ阻害物質としての４−（（２−ヒドロキシ−３−メトキシベンジル）アミノ）ベンゼンスルホンアミド誘導体
WO2016172496A1 (en) 2015-04-23 2016-10-27 Constellation Pharmaceuticals, Inc. Lsd1 inhibitors and uses thereof
FI3532459T3 (fi) 2016-10-26 2023-10-23 Constellation Pharmaceuticals Inc Lsd1-estäjiä ja niiden lääkinnällisiä käyttöjä
JP2024508794A (ja) 2021-02-19 2024-02-28 スドー バイオサイエンシーズ リミテッド Ｔｙｋ２阻害剤およびその使用

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2440649A (en) * 1948-04-27 Quinazoline
GB1108819A (en) 1964-07-31 1968-04-03 Rotta Research Lab Derivatives of 2-acylaminobicarboxylic acids and method for preparing same
DE3332633A1 (de) 1983-09-09 1985-04-04 Luitpold-Werk Chemisch-pharmazeutische Fabrik GmbH & Co, 8000 München Substituierte carbonsaeurederivate, verfahren zu ihrer herstellung, und arzneimittel
DE4102024A1 (de) * 1991-01-24 1992-07-30 Thomae Gmbh Dr K Biphenylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US5424334A (en) 1991-12-19 1995-06-13 G. D. Searle & Co. Peptide mimetic compounds useful as platelet aggregation inhibitors
CA2150550A1 (en) * 1992-12-01 1994-06-09 Melissa S. Egbertson Fibrinogen receptor antagonists
JPH06192199A (ja) 1992-12-25 1994-07-12 Mitsubishi Kasei Corp ケトン誘導体
US5563127A (en) * 1993-03-24 1996-10-08 The Dupont Merck Pharmaceutical Company Boronic acid and ester inhibitors of thrombin
CA2183428A1 (en) 1994-03-11 1995-09-14 John J. Baldwin Sulfonamide derivatives and their use
GB2292149A (en) 1994-08-09 1996-02-14 Ferring Res Ltd Peptide inhibitors of pro-interleukin-1beta converting enzyme
US6306840B1 (en) * 1995-01-23 2001-10-23 Biogen, Inc. Cell adhesion inhibitors
IL122664A (en) 1995-07-24 2000-12-06 Fujisawa Pharmaceutical Co Esters and amides which are phospholipase A2 inhibitors
ATE377006T1 (de) * 1995-11-28 2007-11-15 Cephalon Inc Aus d-aminosäuren abgeleitete cystein- und serinproteasehemmer
ATE320249T1 (de) * 1997-07-08 2006-04-15 Ono Pharmaceutical Co Aminosäurederivate
JP4129069B2 (ja) 1997-09-16 2008-07-30 株式会社Ａｄｅｋａ アシル化ペプチド類の製造方法
JP4090541B2 (ja) 1997-10-15 2008-05-28 株式会社Ａｄｅｋａ アシル化ペプチド類の製造方法
EP1063888A1 (en) 1998-03-27 2001-01-03 The Regents of the University of California Novel hiv integrase inhibitors and hiv therapy based on drug combinations including integrase inhibitors
TWI245035B (en) * 1998-06-26 2005-12-11 Ono Pharmaceutical Co Amino acid derivatives and a pharmaceutical composition comprising the derivatives
US7157430B2 (en) * 1998-10-22 2007-01-02 Idun Pharmaceuticals, Inc. (Substituted)acyl dipeptidyl inhibitors of the ICE/CED-3 family of cysteine proteases
US6242422B1 (en) * 1998-10-22 2001-06-05 Idun Pharmacueticals, Inc. (Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
DE19851184A1 (de) 1998-11-06 2000-05-11 Aventis Pharma Gmbh N-Arylsulfonyl-aminosäure-omega-amide
US6265610B1 (en) * 1999-01-12 2001-07-24 The University Of North Carolina At Chapel Hill Contrast media for angiography
NZ515249A (en) 1999-05-07 2004-07-30 Texas Biotechnology Corp Propanoic acid derivatives that inhibit the binding of integrin alpha4-beta1 to its receptors
US6723711B2 (en) 1999-05-07 2004-04-20 Texas Biotechnology Corporation Propanoic acid derivatives that inhibit the binding of integrins to their receptors
US6493791B1 (en) * 1999-12-20 2002-12-10 Intel Corporation Prioritized content addressable memory
JP2003531894A (ja) 2000-04-25 2003-10-28 サムスン エレクトロニクス カンパニー リミテッド マトリックスメタロプロテアーゼ阻害剤としてのビフェニルブチル酸誘導体
US6723733B2 (en) 2000-05-19 2004-04-20 Guilford Pharmaceuticals, Inc. Sulfonamide and carbamide derivatives of 6(5H)phenanthridinones and their uses
CA2321348A1 (en) * 2000-09-27 2002-03-27 Blaise Magloire N'zemba Aromatic derivatives with hiv integrase inhibitory properties
JP2002145849A (ja) 2000-11-10 2002-05-22 Kyorin Pharmaceut Co Ltd アルキニルアミノ酸誘導体及びその製造法
US20050049242A1 (en) * 2000-12-21 2005-03-03 W. Edward Robinson Novel HIV integrase inhibitors and HIV therapy based on drug combinations including integrase inhibitors
US20040009956A1 (en) * 2002-04-29 2004-01-15 Dehua Pei Inhibition of protein tyrosine phosphatases and SH2 domains by a neutral phosphotyrosine mimetic
AU2004266233A1 (en) 2003-08-13 2005-03-03 Amgen, Inc. Melanin concentrating hormone receptor antagonist
CA2542064A1 (en) 2003-10-24 2005-05-06 Exelixis, Inc. Tao kinase modulators and methods of use
BR0318625A (pt) 2003-12-04 2006-10-31 Wyeth Corp biaril sulfonamidas e métodos para usar as mesmas
CN1894206A (zh) 2003-12-15 2007-01-10 日本烟草产业株式会社 N－取代的n－磺酰氨基环丙烷化合物和其药学应用
US20050261273A1 (en) 2004-03-09 2005-11-24 Varghese John Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
TW200800209A (en) * 2005-07-11 2008-01-01 Wyeth Corp Glutamate aggrecanase inhibitors
DE102006018250A1 (de) 2006-04-13 2007-10-18 Aicuris Gmbh & Co. Kg Verfahren zum Herstellen von cyclischen Depsipeptiden
TW200808715A (en) * 2006-06-02 2008-02-16 Wyeth Corp Methods for preparing glutamic acid derivatives and intermediates thereof

Also Published As

Publication number Publication date
IL190729A0 (en) 2008-11-03
GT200600305A (es) 2007-02-26
AR057451A1 (es) 2007-12-05
CN101282927A (zh) 2008-10-08
RU2008113222A (ru) 2009-11-20
KR20080058436A (ko) 2008-06-25
US20070088172A1 (en) 2007-04-19
ECSP088360A (es) 2008-05-30
WO2007044100A1 (en) 2007-04-19
NO20081617L (no) 2008-05-06
PE20070526A1 (es) 2007-06-11
CA2624866A1 (en) 2007-04-19
US7541485B2 (en) 2009-06-02
AU2006299918A1 (en) 2007-04-19
JP2009511578A (ja) 2009-03-19
EP1934171A1 (en) 2008-06-25
CR9885A (es) 2008-06-16
BRPI0617348A2 (pt) 2011-07-26

Similar Documents

Publication Publication Date Title
TW200800968A (en) Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs
WO2006092213A8 (de) Pyrazolylcarboxanilide
NO20075643L (no) Fremgangsmater for fremstilling av 3-cyano-kinoliner og derved fremstilte mellomprodukter
NO20076371L (no) Fremgangsmate for fremstilling av fenoliske 4-bifenylylazetidin-2-oner
TW200716568A (en) 1H-quinazoline-2,4-diones
MX2009007436A (es) Derivados espirociclicos de acido tetronico.
MX2010004546A (es) Nuevos intermedios de pregabalina y procedimiento para prepararlos y para preparar pregabalina.
TW200740729A (en) Methods for preparing glutamic acid derivatives
MX2009006750A (es) Derivados de azaadamantano espirociclicos y metodos de uso.
TW200800986A (en) Tetrahydroquinolines, synthesis thereof, and intermediates thereto
WO2008053334A3 (en) An improved process for preparing rosuvastatin calcium
TW200738713A (en) Diazepinoquinolines, synthesis thereof, and intermediates thereto
UA100862C2 (ru) Шестичленные ароматические соединения, их получение и применение (варианты)
WO2009062659A3 (en) Polymorphs of enantiopure erdosteine
EA200702428A1 (ru) Способы получения 4-бифенилилазетидин-2-онов
WO2007143014A3 (en) Methods for preparing glutamic acid derivatives and intermediates thereof
NO20065157L (no) Biotransformasjon av colchicinoidforbindelser
MX2008000011A (es) Procesos para preparar derivados de pirazol-o-glucosido y nuevos intermediarios de dichos procesos.
TNSN07462A1 (en) Ampa receptor potentiators
WO2007054970A3 (en) Novel polymorphic forms of (s)-(-)-2-amino-6-(n- propylamino) 4,5,6,7- tetrahydrobenzothiazole
MX2010003056A (es) Polimorfos de valomaciclovir.
WO2007029082A3 (en) An improved fermentation process for preparing ascomycin
WO2007049302A3 (en) An improved process for the preparation of pure venlafaxine
SG155231A1 (en) Process for synthesis of dialkoxyorganoboranes
WO2006082598A3 (en) Novel crystalline forms of rizatriptan benzoate